Dr. Rebecca S. Yu, MD

Dr. Yu practices at Rebecca S. Yu, MD in Berkeley, California.

Dr. Yu's NPI, 1306871231, was assigned on July 11, 2006. Dr. Yu graduated from Feinberg School of Medicine in 1997. Dr. Yu holds California license A88159.

Dr. Yu's primary practice is Rebecca S. Yu, MD, at 3000 Colby St, Berkeley, CA 94705-2058. The practice phone is (510) 540-6800.

Dr. Yu's primary practice is Rebecca S. Yu, MD in Berkeley, California. Dr. Yu is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. Dmand AI also links Dr. Yu to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 5 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Yu is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Yu's licenses on file in 3 states: California, New Jersey and Pennsylvania.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint arthropathy and joint cyst among the conditions Dr. Yu treats.

CMS data shows 1,600 Medicare services from Dr. Yu across 11 procedure codes in 2024, for 398 Medicare patients. Medicare paid $134,768 for them.

CMS counts 398 Medicare patients who saw Dr. Yu in 2024. The largest group is 65 to 74, with 196 patients. 69% of them have high cholesterol, and 60% have arthritis. 8% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 66, with 60% women.

In 2024, Dr. Yu wrote 117 Medicare Part D claims for 56 patients. 100% of them were for generic drugs. CMS names the drug for 74 of them, across 3 drugs with 11 or more claims each, at $409 in total drug cost. In 2023, CMS named 61 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yu for performance year 2024, reported individually. Dr. Yu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yu as offering telehealth. CMS counts 17 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Yu, more than 58% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Yu, published from 2022 to 2025. The most frequent topics are Pancreatic Neoplasms, Antigens, Neoplasm and Carcinoma, Pancreatic Ductal. Dr. Yu has published most often in Nature. Dr. Yu's most frequent co-authors are Vinod P. Balachandran, MD, Kevin Cerqueira Soares, MD and Otis Alton Barron, MD.

CMS Open Payments shows 17 general payments to Dr. Yu from 11 drug and device companies from 2016 to 2025. Education make up the largest share, 73% of the total. Evolution Surgical, Inc paid the most, $1,244.

Dmand AI lists 1 award for Dr. Yu, most recently CMS Stage 1 2012 in 2011.

Dr. Yu graduated from Feinberg School of Medicine in 1997.

Dr. Yu is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.